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SAMMANFATTNING 
Ekvina kutana melanom uppstår mycket oftare hos skimlar än hos hästar med annan pälsfärg. 
En del forskare har dragit slutsatsen att melanomen är neoplasier som kan klassificeras efter 
utseende och utbredning makro- och mikroskopiskt. Ju mer välavgränsade tumörerna är, desto 
mer benigna verkar de vara. Andra forskare menar att hudförändringarna i själva verket är 
resultatet av en störning i pigmenteringen som har att göra med hur hästarnas gråa pälsfärg 
utvecklas. Enligt denna teori är melanomen inte maligna, men har ändå förmågan att sprida 
sig i kroppen. 
De vanligaste områden för primära kutana melanom är undersidan av svansen, det peri-anala 
området, olika områden på huvudet och i anslutning till könsorganen. Vanliga ställen för 
metastaser är bl.a. lymfknutor, blodkärl, bukhinna, mjälte, lungkapillärer, skelettmuskulatur, 
lever, öronspottkörtel, ben och benmärg. 
DNA-studier på skimlar med och utan kutana melanom har visat en koppling mellan vissa 
genotyper och sannolikheten för att utveckla kutana melanom. Detta skulle kunna förklara 
varför skimlar drabbas i mycket större utsträckning än hästar av andra färger. 
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SUMMARY 
Equine cutaneous melanomas arise much more often in horses with a grey coat color than in 
horses of other colors. Some scientists have in different studies come to the conclusion that 
the melanomas are neoplasms which can be classified by examining their histological and 
macroscopic features. The more defined and demarcated a tumor is, the more benign it tends 
to be. Other scientists believe that the skin lesions are the result of a pigmentation disorder 
that is linked to the greying of the coat color. According to this theory, the lesions are not 
malignant although they have the ability to metastasize.  
The most common areas for primary cutaneous melanomas are underneath the tail, the peri-
anal region, different sites of the head and on or close to the genitalia. Common sites for 
metastases are e.g. lymph nodes, blood vessels, the peritoneum, the spleen, capillaries of the 
lungs, skeletal muscle, the liver, the parotid salivary gland, bone and bone marrow. 
Studies of the DNA from grey horses with and without cutaneous melanomas have shown a 
correlation between certain genotypes and the likelihood of developing cutaneous melanomas. 
This could explain why grey horses are much more probable to develop these tumors than 
horses of other colors. 
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INTRODUCTION 
Equine cutaneous melanomas are far more commonly observed in grey horses than horses of 
solid colors. The melanomas have different features, both macroscopically and 
microscopically, which can be predictive of prognosis and malignancy. The objective of this 
study of literature regarding cutaneous melanomas in grey horses is to describe the nature and 
etiology of these lesions. Not everyone doing research in the field of cutaneous melanomas 
believe that these are in fact true neoplasms. I have focused on why grey horses are more 
likely to be affected than horses of other colors. A classification of different tumors, as well as 
common sites for primary lesions and metastases is also addressed.  
When working as a veterinarian, these things are important to have insight in so that correct 
diagnosis can be made. The diagnosis is essential for the expected prognosis of a tumor, and 
will therefore have a great impact on any decision (e.g. concerning treatment) an owner of a 
melanoma-bearing horse might have to make. Also, I believe that gaining more knowledge 
about neoplasms in one species will only help us to understand more about cancer in other 
species, such as humans.  
MATERIALS AND METHODS 
When searching for articles I used multiple on-line databases, but mostly PubMed 
(20110201), Google Scholar (20110201) and Web of Science (20110215). With search terms 
such as (melanom* OR neoplasm* OR pigmentation disorder*) AND (horse* or equine) 
AND (grey OR gray) the search results were reviewable. Many articles seemed very well 
grounded and interesting when reading the abstracts, but unfortunately I found that they were 
often written in German or other languages. I could therefore not include them in my 
literature study, since I only understand English and Swedish. 
RESULTS 
Description, definition and classification 
The grey horse 
A grey horse is born with a dark fur coat and dark skin. With each shedding, the fur becomes 
lighter and lighter until finally turning white. The skin however stays dark throughout the 
horse’s life. Dermal melanomas in grey horses are very common, with 70-80% of all grey 
horses affected by the age of 15 years (M’Faydean, 1933). 
Cutaneous melanomas 
Melanomas derive from the mature, pigment producing cells found in the skin and in other 
areas of the body. These cells are called melanocytes and originate from the neuroectoderm 
(Moulton, 2002). In a study of 53 horses with cutaneous melanoma four different tumor 
patterns were recognized (Valentine, 1995): 
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 Melanocytic nevi (29 horses) 
o Average 5 years of age, any coat color (17 greys, 12 of other colors). 
o Histologically distinguishable from other tumor patterns.  
o Benign, involving superficial dermis and/or the epidermal-dermal junction.  
Others have added more features to the description of the melanocytic nevi: 
o Common sites for these tumors are legs or trunk, whereas they are rarely found 
in the area of the tail, perineum or genitals (Scott & Miller 2011). 
o In some literature referred to as melanocytomas. Depending on their location 
within the layers of the skin they can be classified as junctional, intradermal or 
compound (Jones & Hunt, 1997). 
 
 Dermal melanoma (8 horses) 
o Average 13 years of age, only grey horses.  
o Solitary demarcated, hemispheric nodules involving deep dermis.  
o Metastasizes sometimes (2 of 6 horses at follow-up).  
 
 Dermal melanomatosis (12 horses)  
o Average 17 years of age, only grey horses.  
o Histologically similar to dermal melanoma but distinguished from this by 
clinical features. 
o Infiltrative plaque with or without associated nodules involving deep dermis. 
o  Will often metastasize (6 of 6 horses at follow-up). 
 
 Anaplastic malignant melanoma (2 horses) 
o Older horses of all colors. 
o Histologically distinguishable from other tumor patterns.  
o Large, locally invasive, often poorly pigmented. 
o Metastasizes quickly. 
Fleury et al., (2000a) described equine cutaneous melanomas to be of mainly two different 
characters; either they were nodule-like or plaque-like (Table 1). The latter was mainly 
observed underneath the tail of the horses, and when the plaques were large they were also 
associated with nodules. These observations correspond well to the classifications determined 
by Valentine (1995) regarding dermal melanoma and dermal melanomatosis. Histologically 
the two tumor types were of mainly two patterns, or a mixture of these. Fleury et al., (2000a) 
speculated in whether all plaque-like tumors transform into nodule-like tumors. They 
supported their theory with the finding that tumor cells were present in the periphery of 
apocrine sweat glands in both tumor types. The authors also believed all the tumors they 
found were of a melanomatosis type described by Valentine (1995). In contradiction to 
Valentine (1995), Fleury et al., (2000a) thought that some of the melanomas found might 
originate from the apocrine sweat glands and not from melanocytes. “Ulceration of the 
lesions, as well as mutilation such as loss of the tail were observed in advanced cases. In very 
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rare instances, we observed subcutaneous masses of pigment in the parotid gland region. 
Observed complications of melanomas were considered to be due to mechanical scratches by 
feces or infection of wounds. The animals with severely developed tumors in peri-anal 
regions had diarrhea and transit difficulties leading to cachexy.” Cited from Fleury et al., 
(2000a).  
Table 1. Two different types of cutaneous melanoma tumors and their characteristics, as described by 
Fleury et al., (2000a)  
 Nodule-like tumors Plaque-like tumors 
Appearance Black or blue, hemispheric, raised 
from the skin surface 
Infiltrative plaque, when larger 
associated with nodules 
Size 0,5 – >10 cm in diameter 
1,5 – 5 cm in height 
5 – 20 cm in diameter 
Macroscopic features Tumor masses were heavily 
pigmented, round and extruding 
from epidermis, although only 
involving dermis. 
Pigmented areas in subcutis, distant 
from epidermis; occasionally larger 
round pigmented masses. No extrusion 
from epidermis. 
Microscopic features Heavily pigmented areas 
consisted of concentric ring of 
cells separated by connective 
tissue. In association with these 
areas, lightly pigmented tumorous 
masses were found, similar to 
those near apocrine sweat glands 
in the plaque-like tumors. 
Apoptotic bodies were present. 
Small, lightly pigmented cell masses 
with atypical melanocytes in 
association with apocrine sweat glands; 
as well as larger, heavily pigmented 
cell masses in reticular dermis. The 
melanocytes were large, irregular and 
clear with large nuclei. Melanophages 
were present containing a variation in 
the amount of granula. 
 
In another study, 58 grey horses, mostly Spanish Pure Breed (SPB) or crossbreeds of SPB, 
were examined to determine whether the cutaneous melanomas of grey horses are in fact 
neoplasms, or if they are the result of a pigmentary disorder, as some believe. 52 of the 58 
horses had what the authors, Rodríguez et al., (1997), called dark melanotic (DM). Based on 
the description of theses DMs, they seem to be same type of lesion that has been referred to as 
cutaneous melanomas by previous authors. Leukotrichia (whiteness of the fur in a 
circumscribed area) was seen in 6 horses. Biopsies were taken from normal looking skin, 
primary DM and metastatic DM. The tissues were treated with special antibodies serving as 
markers so that melanocytes as well as macrophages could be detected. Also, a marker 
indicating nuclear proliferation was used to determine the proliferative rate of the DMs. DM 
was found in all horses older than 10 years, and was observed in horses as young as 3 years. 
In 34 cases, the DMs were solitary, and in 18 cases they were multiple or a combination of 
multiple and solitary. The DMs were of different shapes and sizes, and black or grey except in 
5 cases where they were ulcerated and/or depigmented. Necropsy was performed on 9 horses, 
2 of in which no DM was found, and 1 in which DM was detected only after sectioning the 
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skin of the tail. Lymph nodes and parotid glands were involved in 5 cases each, and serous 
membranes and muscles in 4 cases each. Sites of primary tumors are summarized in Figure 1. 
Histologically, neither the skin lesions nor DM in internal organs showed any signs of 
malignancy (no junctional activity in skin lesions and almost no inflammation). Instead, the 
lesions were found to have an appearance reminding of human blue nevi, similar to melanotic 
nevi in horses. The authors suggested that DM therefore might not be a neoplasm. Intensely 
pigmented cells were observed in peri-follicular and peri-vascular arrangements. The DMs 
increased in size with age and involved the superficial and deep dermis. They consisted 
mainly of melanocytes and melanophages. No junctional activity was observed. The marker 
used to detect nuclear proliferation showed a proliferation index of 1-2 % in the skin and 1 % 
in metastases. This is indicative of benign or non-neoplastic processes. The authors believed 
this further supported the theory that DMs are the result of a pigmentation disorder and not 
neoplasms (Rodríguez et al., 1997). 
Common sites of primary tumors 
In the previously mentioned study of 264 grey Camargue-type horses by Fleury et al. (2000a), 
83 were found to carry melanoma. Examination of these 83 horses showed that the most 
common sights for primary lesions were underneath the tail and the peri-anal region (Figure 
1). 
 
Figure 1. Common sites of tumors in Camargue-type horses and Spanish Pure Breed and crossbreeds. 
*In the two studies, sites for tumors were defined in different ways. After Fleury et al., (2000a); 
Rodríguez et al.,(1997). 
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Common sites of metastases 
In the study of 83 Camargue-type horses with cutaneous melanoma, necropsy was performed 
on four horses. Metastasis was detected in primarily regional and distant lymph nodes, but 
also in the parotid gland, the linear peri-lymphatic area in the inter-costal spaces, thoracic 
lymphatic vessels between effected nodes, the lungs, the liver and the peritoneum. Horses 
affected with melanoma in this study were rarely found to suffer from loss of function of 
organs due to metastasis to visceral areas. Signs of dysfunction were only present when 
several inner organs had been affected. (Fleury et al., 2000a). 
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Figure 2. *Meaning all blood vessels except alveolar capillaries. After MacGillivray et al.  (2002).  
14 horses with histologically confirmed melanoma in areas other than the epidermis were 
studied by MacGillivray et al., (2000) at an animal hospital. All horses were older (median 
age was 16.5 years). Their patient records were examined and a gross post mortem 
examination had been performed on all horses. Even though no selection for coat color was 
made in the studied horses, all 14 horses that were diagnosed with metastatic melanoma at the 
hospital during the study period were grey. Characteristic skin tumors were present in 11 
horses. In one horse with no cutaneous masses the parotid salivary gland was thought to be 
the area of the primary tumor.  11 horses had tumors involving the peri-anal and anal region, 
and 9 of these 11 horses also had tumors underneath their tail. In 7 horses, subcutaneous 
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masses were detected, and in 2 horses masses were found in adipose tissue. The primary 
complaints for which the owners of the horses had brought them to the hospital included 
weight loss and depression, dermal melanoma, epistaxis, ataxia, colic, peripheral edema and 
respiratory distress. The cause of death was metastatic melanoma in 12 of the horses (natural 
or euthanized). Weight loss, depression and dermal melanoma were the primary complaints in 
4 cases. Before euthanization, rectal examination was performed in 2 of these horses. Intra-
abdominal masses were detected in both cases. In 9 of the other 10 horses antemortem 
diagnostic tests were performed and metastatic melanoma was confirmed in 5 cases. 4 of the 
10 horses were rectally examined and intra-abdominal masses were detected in all 4. 2 horses 
were presented with epistaxis, and both were found to be anemic. Upper respiratory 
endoscopy was performed and melanoma was found in one or both guttural pouches of both 
horses. The most common sites for metastasis according to the study by MacGillivray et al. 
(2002) are summarized in Figure 2. 
Histology and Immunohistology 
From studying the 14 horses with metastic melanoma, MacGillivray et al., (2000) made some 
histological observations. The neoplastic melanocytes were found to have large, round or 
ovoid and euchromatic nuclei with distinct nucleoli. They were spindloid to stellate in shape, 
and surrounded by melanophages of different sizes. Mitotic figures were rarely observed. In 
all 14 horses the histological features were similar except in one case where the cells had the 
appearance of an anaplastic malignant melanoma. 
In 2004, Seltenhammer et al., had the objective to compare human malignant melanoma and 
grey horse melanoma. Focusing on the latter, 27 tissue samples from histologically confirmed 
cutaneous melanoma from grey horses (16 benign, 11 malignant) and four tissue samples 
from malignant melanoma in solid colored horses were examined. 11 non-melanomic equine 
tissue samples were used as controls. Melanomas were dominated by different types of cells, 
for example spindle cells, epithelioid cells, or a mixture of the two. Three different types of 
melanoma were distinguished (Seltenhammer et al., 2004): 
 Benign dermal grey horse melanoma. Homogenous, often with a pseudo-capsule. 
Well-defined areas of heavy pigmentation, often in association with apocrine sweat 
glands or skin adnexa. Mixed cell type tumors were a common feature. Melanophages 
associated with apoptosis in the center of tumors as well as nuclear atypia was also 
observed. Immunostaining showed highly proliferative melanocytes in the margins of 
tumor areas. 
 Malignant dermal grey horse melanoma. The sizes of cells and nuclei differed between 
cells, and mitotic figures were observed. Pleomorphic epithelioid cells and balloon 
cells were the most common cell types. The tumor areas were diffusely defined, and 
the pigmentation ranged from heavily pigmented to amelanotic areas. In some cases 
vascularization was increased and activated lymphocytes could be seen.  
 Anaplastic malignant solid-colored horse melanoma. Mitotic activity was high and 
vascular as well as lymphatic invasion was seen. Tumor cells often had two nuclei and 
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were mainly pleomorphic polyhedral and epithelioid cells. Tumor areas were vague, 
and in two cases tumors were amelanotic. Also, in two cases there was junctional 
activity where the epidermis was ulcerated. 
Melanomas were located in dermis and/or subcutis. Specific for the grey horse melanomas 
was that no tumor cells were seen in the dermal-epidermal junction. With the exception of 
two malignant tumors, none of the tumors involved epidermis (Seltenhammer et al., 2004).  
The proliferation markers Ki-67 and PCNA used in immunohistology were found to help 
distinguish between benign and malignant tumors (Seltenhammer et al., 2004). The 
melanocyte differentiation antigen gp100 occurred much more frequently in malignant tumors 
than benign. The authors came to the conclusion that based on the immunohistological and 
histological features seen in these tumors, they are in fact neoplasms and not pigment storage 
disorders as Rodriguez et al., (1997) believed. Scott & Miller (2011) on the other hand, 
reported that no difference could be detected in Ki-67 or PCNA when comparing metastatic 
and benign melanomas, and that these markers therefore were of no use concerning 
predictability of tumor behavior. 
The melanoma-associated antigens Melan-A, MAGE-1, MAGE-3 and PCNA were found to 
be expressed at higher levels in faster proliferating cells in cell cultures (Chapman et al., 
2008). MAGE-genes are not expressed in melanotic nevi but are often found in malignant 
cutaneous melanomas of humans. Immunohistochemical staining for these genes might 
therefore be an important prognostic tool (Busam et al., 2000). 
Etiology 
Although different theories have been presented on how dermal melanomas and 
melanomatosis arise, the actual mechanism has not yet been determined. One theory describes 
that the altered metabolism of melanin is the initial cause. In greying horses, melanin is 
produced by melanocytes, but the melanin granula is not incorporated into the hair follicles, 
and therefore the hairs become unpigmented. The altered metabolism leads to hyperplasia of 
melanoblasts, either by new melanoblasts forming, or by increased activity of existing 
melanoblasts. The hyperactivity results in overproduction of melanin, and it is here that 
hyperplastic melanoblasts are thought to become malignant. In contrast to the development of 
melanomas in humans, exposure to UV-light is not considered a risk factor, since these 
tumors in grey horses often arise in shaded areas such as the peri-anal region (Scott & Miller, 
2011). 
In another article written by Fleury, et al. (2000b) it was found that the onset of the melanoma 
occurred most frequently between five and nine years of age in Camargue horses. Gender did 
not seem to be a risk factor. Because tumors were most frequently found in the shady areas of 
the peri-anal region and underneath the tail, sunlight was not considered to be a risk factor 
either. When taking in mind the areas where tumors were most frequently found, the authors 
suggest that it is likely that the pathogenesis for these tumors is associated with mucus-
associated, hairless, thin skin. 
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A study was performed on 296 grey Lipizzaner horses older than four years to gain further 
knowledge on the impact of heritability on, and the occurrence of, melanocytic tumors. All 
horses had pedigrees that could be traced back up to 32 generations. Out of the 296 horses, 
148 (50 %) were found to be melanoma bearing. 75.6 % of affected horses had tumors 
underneath their tail, but only 4.3 % of the tumors were located in the peri-anal and anal 
region. In 50 % of the peri-anal and anal tumors, depigmentation similar to vitiligo was 
observed in the same area. This was mostly seen in older horses. A 0-5 scale was used to 
evaluate the severeness of the tumors (0 being free of melanoma, 5 being ulcerated tumors, 
spread to internal organs and causing secondary symptoms such as fever and diarrhea). 
Although several horses were found to be stage 4 cases (“Extensive confluent melanoma, 
covered with skin, signs of destruction (necrosis, ulceration) and metastasis”, cited from 
Seltenhammer et al., (2010)), none of them showed any clinical illness. This supported the 
authors’ theory that cutaneous melanocytic tumors in grey horses show less malignancy than 
in horses of solid colors. Comparing the prevalence of melanomas in horses from different 
studfarms, the authors found that hereditability had a statistically significant effect on the 
development of the tumors (Seltenhammer, M.H. et al., 2010). 
Genotype and melanoma 
The grey phenotype has been shown to be caused by a duplication in an intron (STX17), 
resulting in a cis-acting regulatory mutation (Rosengren Pielberg et al., 2008). A cis-
regulatory is an area of the DNA-molecule that will regulate the expression of a gene on the 
same chromosome. It was also shown that the gene carrying the mutated intron, along with a 
neighboring gene, were both overexpressed in melanomas found in grey horses. The 
prevalence of melanoma was found to be higher in horses carrying a loss-of-function 
mutation in ASIP (agouti signaling protein). Four genes were found in the region of the 
mutation causing the grey color, and all these four genes were expressed in melanomas. 694 
grey Lipizzaners were genotyped for the duplication in STX17. It was found that horses with 
a homozygote duplication shifted from dark grey to white much faster than heterozygote 
Lipizzaners. The prevalence for melanoma and vitiligo was much lower in the heterozygote 
horses. The authors believed that the duplication acts predisposing for the development of 
melanoma by stimulating the dermal melanocytes to proliferate. (Rosengren Pielberg et al., 
2008).  
Using Northern blotting analysis, the expression of two melanocyte-specific antigens was 
found to differ between grey and solid-colored horses. In solid-colored horses normal levels 
of mRNA were found, in grey unaffected horses none was detected but in tumor samples from 
grey horses expression was high. The fact that there was no expression in the grey, healthy 
horses was thought by the authors to indicate a roll in the depigmentation of greying horses. 
Pedigrees and phenotypic information for 71 different Camargue horses was analyzed using 6 
different heritability models. The results supported the theory that prevalence for melanoma 
in grey horses is strongly correlated to the horses’ genetic heritage. Therefore, the authors 
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believed that selection for melanoma-free horses would have an important impact on health 
for grey horses. Although they are far more susceptible to the cutaneous melanoma, 
malignancy is much rarer than in solid-colored horses. The authors of this article suggested a 
possible hypothesis regarding this. Because of the reduced activity of melanocytes in greying, 
aging horses, tumor growth and metastasis might progress in a much slower way. This allows 
the grey horse to stay healthy and unaffected for a much longer time than a solid-colored 
horse with the diagnosis of cutaneous melanoma (Rieder, S. et al., 2000). 
DISCUSSION 
As the study by Valentine (1995) was the first one I read when researching cutaneous 
melanomas in grey horses, the patterns she described for different melanomas became a 
benchmark when reading other articles. I find that tumors studied by other scientists for the 
most part fit well into the classifications melanocytic nevi (being benign), dermal melanoma 
(which will metastasize sometimes), dermal melanomatosis (which will often metastasize) or 
anaplastic malignant melanoma (which will metastasize quickly). Dermal melanoma seems to 
be the same type of tumor as Fleury, C. et al. (2000a) describe as nodule-like tumors, in the 
same way that dermal melanomatosis is what Fleury, C. et al. (2000a) call plaque-like tumors. 
However, it should be stressed that the melanocytic nevi, although occurring in horses of all 
colors, seem to be more frequently occurring in grey horses. Drawing any definite 
conclusions regarding color of the fur from studying 29 horses with melanocytic nevi is 
questionable. Nor should any conclusions be drawn about fur color when only 2 horses with 
anaplastic malignant melanoma were included. I would propose a study on a larger number of 
horses before agreeing with Valentine (1995) on this matter. 
When reading different articles about the cutaneous melanomas in grey horses, I find that the 
results from some studies lead to different conclusions about this disease. Several different 
studies support the theory that these lesions so commonly seen in grey horses are neoplasms 
(Valentine, 1995; Fleury et al., 2000a; MacGillivray 2002; Seltenhammer 2004, 2010). 
Rodríguez et al. (1997) on the other hand, found that no signs of malignancy could be 
observed when the lesions were studied histologically. Also, the proliferation index was low, 
indicating that the lesions were not neoplastic. Instead, Rodriguez et al. (1997) believed the 
alternated areas of skin to be the result of a pigmentation disorder. I consider the nature of the 
lesions being neoplastic is far more likely and well-grounded than arising from a 
pigmentation disorder. I say this because different study groups in various countries have 
reached the same results and found the same patterns in the different types of cutaneous 
melanoma. The histological patterns that were described by Rodríguez et al. (1997) seem like 
the melanocytic nevi described by Valentine (1995). If all horses studied by Rodríguez et al. 
(1997) had melanocytic nevi and not dermal melanoma, dermal melanomatosis or anaplastic 
malignant melanoma, it is natural that no malignancy was found. This might explain why his 
results differ from the work of others. 
How common different sites are for primary tumors of the dermal melanoma and dermal 
melanomatosis types differ slightly between studies. Underneath the tail and the peri-anal 
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region are by far the most frequently affected areas, followed by various sites of the head such 
as lips, eyelids and parotid gland; and genitalia (Rodríguez et al., 1997; Fleury et al. 2000a). 
At times, I find that the statistics are presented in a misleading way. For example, the 
prevalence of cutaneous melanocytic tumors in female genitalia is reported to be 3.44% 
(Rodríguez et al., 1997). When looking closer at the facts, one finds that these 3.44 % actually 
account for 2 cases out of 2 females which have been compared to the whole group (2 females 
and 56 males). In my opinion, results regarding gender should be divided into different groups 
when considering gender specific aspects of the tumors. Therefore, a more correct description 
of the prevalence of tumors in female genitalia in this case would be 100% (2 cases in 2 
females).  Fleury, et al., (2000a) found the prevalence of tumors in female genitalia to be 3.8 
%. Nowhere in the article do the authors specify how many of the horses were females. This 
is also to be considered as a serious shortcoming. Naturally, the same reasoning should be 
applied to the prevalence of tumors in the male genitalia presented in both articles. 
Metastasis of the equine cutaneous melanomas can occur in many different places throughout 
the body. In the study performed by MacGillivray et al., (2002), lymph nodes and blood 
vessels were the most common sites of metastases (64 %). This indicates that the neoplasms 
spread both with blood and lymph. The peritoneum and associated structures, the spleen, 
skeletal muscles, alveolar capillaries, the parotid salivary glands and bone or bone marrow are 
other common sites of metastases. 
It is interesting to read about the possibility to stain for MAGE-genes in humans. If the 
method also could be applied to cutaneous melanomas of horses, it might help predict the 
malignancy of a tumor. This would probably have a great impact on both prognostics and 
decisions concerning what therapy, if any, would be best. For example, one would quickly try 
to surgically remove a tumor with a high expression of MAGE-genes to avoid or minimize 
metastasis. More research is needed to see if this could be predictive of malignancy in the 
equine tumors. 
Rosengren Pielberg et al. (2008) found that horses with a homozygote duplication in the 
STX17 intron were at much higher risk of developing melanoma than heterozygote horses. I 
believe this is a trustworthy explanation to the high prevalence of cutaneous melanomas seen 
in grey horses compared to solid-colored horses. The duplication is linked to the grey fur 
phenotype and is only observed in grey horses. These results correspond well to the findings 
of Rieder et al., (2000). I agree with the ideas of Rieder et al., (2000), that when selecting 
horses for breeding who are likely to produce offspring of the grey phenotype, the genotype 
should be considered. By doing this one can probably reduce the incidence of cutaneous 
melanoma. More research on this area is needed. It would be of great value if for example a 
relatively cheap blood test indicating if a certain horse is homozygote or heterozygote for the 
STX17 intron duplication could be developed. 
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